The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials

The neoadjuvant and adjuvant anti-PD-1/PD-L1 treatment has been increasingly noticed. To summarize the global landscape of these clinical trials will provide essential data for all the stakeholders of drug development. Based on the Trialtrove database, a total of 668 clinical trials initiated by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dawei, Huang, Huiyao, Zhang, Minghui, Li, Ziwei, Wang, Shuhang, Yu, Yue, Fang, Yuan, Jiang, Ning, Miao, Huilei, Ma, Peiwen, Tang, Yu, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822713/
https://www.ncbi.nlm.nih.gov/pubmed/35135567
http://dx.doi.org/10.1186/s13045-022-01227-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822713/
https://www.ncbi.nlm.nih.gov/pubmed/35135567
http://dx.doi.org/10.1186/s13045-022-01227-1

Ejemplares similares